SAN DIEGO, CA, USA I5, 2025 I Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused ...

Fully funded multi-center study initiated at University of Florida to further explore efficacy of isomyosamine for preventing progressive muscle loss and ...

PASADENA, CA, USA I February 25, 2025 I Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company’s ...

SEONGNAM, South Korea I February 25, 2025 I SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention ...

CAMBRIDGE, MA, USA; ROTTERDAM, The Netherlands and SHANGHAI, China I5, 2025 I HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology ...

MELBOURNE, Australia I6, 2025 I Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United ...

RESEARCH TRIANGLE PARK, NC, USA I5, 2025 I Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies, today ...

SAN JOSE, CA, USA I5, 2025 I BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditionally “hard-to-drug” targets, announced today a strategic collaboration and ...

HEFEI, China I February 25, 2025 I Kangpu Biopharmaceuticals, Ltd. ("Kangpu") today announced that the Company has received IND approval from the CDE (Center ...